Skip to content
Review

Long non-coding RNAs in colorectal cancer: shaping the tumour microenvironment and advancing precision oncology.

Sep 2026 · Nature reviews: Gastroenterology & hepatology · 0 citations · 171 references
Medicine

TL;DR

This Review explores the dual roles of lncRNAs as oncogenes or tumour suppressors, their involvement in immune modulation, vascular remodelling and extracellular matrix dynamics, and their involvement in immune modulation, vascular remodelling and extracellular matrix dynamics.

View source

Similar papers

#gene editing Review Open access Aug 2026

The emerging roles of non-coding RNAs in cancer.

This review examines how different types of ncRNAs contribute to cancer initiation, progression, and treatment resistance, and assesses their potential as diagnostic markers, prognostic factors, and therapeutic targets.

Akanksha Samuel, G. Calin · 0 citations
Review Open access Aug 2026

Long non-coding RNAs at the crossroads of inflammation, cancer and angiogenesis: Molecular mechanisms and their potential as therapeutic targets.

This work discusses new discoveries which highlight the value of lncRNA targeting as therapeutic applications, in gastrointestinal inflammation and cancer angiogenesis, and identifies gaps in the current knowledge and understanding.

Charlie Leboff, Pamela Calle-Mendoza, M. Hatziapostolou et al. · 0 citations
Review Aug 2026

Long non-coding RNAs as master regulators of cancer metastasis and therapeutic resistance.

This review systematically summarize current advances in lncRNA-mediated regulation of cancer metastasis and drug resistance, with particular emphasis on their roles in oncogenic signaling cascades, transcriptional control, immune cell reprogramming, and metabolic remodeling.

Dong Liang, Jing-Wen Zheng, Zheng-Dan Gao et al. · 0 citations
Review Open access Aug 2026

Non-coding RNAs as regulators of chromosomal instability in breast cancer

The available evidence supports an emerging role for ncRNAs as regulators of CIN while underscoring the need for further mechanistic and subtype-specific studies to validate their clinical utility.

Deisy Pinilla-Peña, Anlly Niño-Salgado, Milena Rondón-Lagos · 0 citations
Review Aug 2026

The regulatory role of non-coding RNAs in taxane resistance of breast cancer.

Targeting ncRNAs via various therapeutic approaches, including herbal compounds and synthetic peptides, has shown hopeful findings in reversing taxane resistance in breast cancer, highlighting a promising avenue for the management of taxane resistance in breast cancer.

Cui-Cui Sun, Lingling Lv, Qinzheng Xu et al. · 0 citations
Review Open access Aug 2026

Dark matter matters: from noncoding RNA regulation to cancer immunity

These findings call for a revised molecular dogma in which the noncoding genome is recognized as a major regulator of cellular function, oncogenic transformation, and immune surveillance.

Maria Lteif, Assia Hijazi, E. Morgand et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.